Factor H polymorphism elevates granzyme B and impairs complement inhibition in human and mouse models
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Vancouver Coastal Health Research Institute
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
This publication has 67 references indexed in Scilit:
- Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularizationAngiogenesis, 2024
- Granzyme B Contributes to Choroidal Neovascularization and Age-Related Macular Degeneration Through Proteolysis of Thrombospondin-1Laboratory Investigation, 2023
- Relationship between Systemic Cytokines and Complement Factor H Y402H Polymorphism in Patients With Dry Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 2013
- Granzyme B in injury, inflammation, and repairTrends in Molecular Medicine, 2012
- Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complexMolecular Aspects of Medicine, 2012
- Complement dysregulation in AMD: RPE-Bruch’s membrane-choroidMolecular Aspects of Medicine, 2012
- Elevated membrane attack complex in human choroid with high risk complement factor H genotypesExperimental Eye Research, 2011
- Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasionInternational Journal of Cancer, 2010
- Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular DegenerationJAMA, 2007
- Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cellsCell, 1994